 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)物質(zhì) > 農(nóng)殘標(biāo)準(zhǔn)物質(zhì) > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：H102455 |
| 產(chǎn)品名稱：Halofenate |
| 產(chǎn)品CAS：26718-25-2 |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
H102455 |
| 名稱: |
Halofenate |
| 別名: |
(p-Chlorophenyl)[(α,α,α-trifluoro-m-tolyl)oxy]acetic Acid Ester with N-(2-Hydroxyethyl)acetamide; 2-Acetamidoethyl (p-Chloro-phenyl)-(m-trifluoromethyl-phenoxy)acetate; 2-Acetamidoethyl 4-Chlorophenyl(3-trifluoromethylphenoxy)acetate; Halofenate; MK 185; 2-Acetamidoethyl 2-(4-Chlorophenyl)-2-(3-(trifluoromethyl)phenoxy)acetate; |
| CAS號(hào): |
26718-25-2 |
| 分子式: |
C??H??ClF?NO? |
| 分子量: |
415.79 |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Halofenate is a selective peroxisome proliferator-activated receptor γ (PPARγ) modulator with antidiabetic activity. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
